As I mentioned over the weekend, I bought two different stocks last month. My first purchase was drug company Abbvie (ABBV). In the previous post I outlined how Abbvie was a riskier company, but had numerous strengths and a strong dividend yield. My 2nd stock was none other than Altria (MO). Altria Group Inc. is the parent … [Read more...]
Recent Buy: ABBV
For the month of September, I went after a deep discount but took on some risk. I purchased 16 shares of Abbvie (ABBV) at a price of around $65/share. Abbvie is a global researcher, manufacturer, and marketer of pharmaceuticals. Products developed treat conditions related to autoimmune disorders, gastroenterology, neurology, oncology, … [Read more...]
Building Connections & Abolishing Fear
I recently made two additional stock purchases for the month of September. I’ll be going over these securities in subsequent posts. Needless to say, I found these two companies to be undervalued and unfairly punished by the market. I want to discuss this issue, where Wall Street punishes particular stocks for bad news, poor earnings numbers, and … [Read more...]
Recession Fears
In my last post we discussed the slowdown in the industrial sector and how it is affecting companies like 3M. However, on a global scale, other sectors appear to be contracting. More specifically, we’re seeing a mild recession in Germany and growth in China slowing dramatically. The U.S. appears to be the bright spot. Yes, industrial companies … [Read more...]
Recent Buy: MMM & JNJ
For my July purchase I added to my portfolio core. Some of my favorite companies were facing challenging short-term headlines, presenting buying opportunities. JNJ is facing criminal allegations on whether or not they knew about the toxicity of their baby powder. At the same time, 3M is threatened by a trade war with China and a possible … [Read more...]
No Alternative
Due to trade uncertainties, the market is pricing in an interest rate cut at the end of the month. During the July 30-31st Fed meeting, officials are 100% expected to cut interest rates by 25 basis points. Furthermore, this comes with the possibilities of future rate cuts in late 2019 and early 2020. This means borrowing costs will decline and … [Read more...]